InvestorsHub Logo
Followers 151
Posts 4572
Boards Moderated 0
Alias Born 05/06/2010

Re: None

Thursday, 05/20/2021 11:48:54 AM

Thursday, May 20, 2021 11:48:54 AM

Post# of 1030
Strainsforpains Inc. shareholder announcement ( OTC Symbol: EBYH) New York, N.Y., May 20, 2021.

The company is pleased to announce further progress in its goal towards its strategy of becoming a distributor and marketer of CBD/CBG products. The company’s Pennsylvania property is in the process of being retrofitted into a production facility for these products. The company has been test marketing its CBD/CBG products and the response has been substantial.

The benefits of combining CBD and CBG together has been in line with the demand for higher quality products. “Our products will provide higher quality and exceptional health benefits for those looking for relief from pain. The combination of CBD and CBG balance each other’s benefits out. Our studies have shown that users had beneficial effect for both pain and depression”, said Yehoshua Shainberg.

Our Strainsforpains APP has continued to expand, and we will soon be announcing a joint venture with a medical organization that will exclusively utilize our technology for their patients. The company is excited for its future in educating health professionals to realize the thousands of variations of Canna products in combination with CBD/CBG that have beneficial results for those in pain.

The company is also pleased to announce that it has been negotiating with several sports and entertainment figures with regards to promotion of its products and services. We will announce in our second quarter, a list of NFL and entertainment figures, in Arizona and California, that will help us get to the next stage in our development, as a company that helps those in need with access to technology services and products.

The company is also pleased to announce that our president, Yehoshua Shainberg, is a member of the prestigious International Cannabinoid Research Society, and will be participating in this year’s annual ICRS conference. ICRS is made up of approximately 1600 MD’s, PhD’s, and those recognized for contributions in research and development in this field.